Synthetic Human Tissues and Body Parts. SynDaver Model for State-of-the-Art Learning. Synthetic Death in Northern Iowa. Pediatric Open Heart Surgery with SynDaver. SynDaver on STEM Journals at UAZ Phoenix. US Navy Uses SynDaver in Wound Research.

We are a late-stage biopharmaceutical company leveraging recent scientific insights on our lead therapeutic candidate entinostat in the emerging field of immuno-oncology. Due to its distinctive mechanism and preclinical and clinical activity observed to date, we believe entinostat holds great promise as a cornerstone combination therapy for a broad range of cancers.

We are a PvP Corporation flying under the NRDS policy.

Data base for Bancassurance products, new products of banks, Tier-II bonds, etc.